Atrial Fibrillation in Cryptogenic Stroke and TIA
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Atrial Fibrillation
Related studies linked through entity extraction aliases.
Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
- Status
- COMPLETED
- Phase
- PHASE3
Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study
- Status
- RECRUITING
- Phase
- PHASE2
Metformin as an Upstream Therapy in Atrial Fibrillation
- Status
- TERMINATED
- Phase
- PHASE2
Catheter Ablation of Longstanding Persistent Atrial Fibrillation
- Status
- UNKNOWN
- Phase
- NA
The Effect of Magnesium Therapy to Prevent Post-operative Atrial Fibrillation After Cardiac Surgery in Adults
- Status
- COMPLETED
- Phase
- NA
NOACs for Atrial Tachyarrhythmias in Congenital Heart Disease
- Status
- UNKNOWN
- Phase
- N/A
CLOSE to CURE Study
- Status
- COMPLETED
- Phase
- NA
Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients
- Status
- COMPLETED
- Phase
- NA
Comparison Between Contact Force Guided and Blinded Strategy on PV Isolation in AF Patients
- Status
- COMPLETED
- Phase
- NA
Comparison of High Versus Escalating Shocks in Cardioverting Atrial Fibrillation
- Status
- COMPLETED
- Phase
- NA
Use of a High Density Mapping System to Complete Wide Area Circumferential Ablation of the Pulmonary Veins and Avoid Ostial Segmental Ablation
- Status
- TERMINATED
- Phase
- NA
Breathing Intervention for Cardiac Anxiety
- Status
- TERMINATED
- Phase
- NA
Comparison of the Ganglionated Plexi Activity in Patients With Different Forms of Atrial Fibrillation Guided by SUMO Technology
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Comparison of Recurrence of Atrial Fibrillation Post Cryoballon Ablation During the 90-day Blanking Period-with and Without Anti-arrhythmic Drug Therapy
- Status
- COMPLETED
- Phase
- NA
Non-vitamin K Oral Anticoagulants in Cardioversion
- Status
- COMPLETED
- Phase
- N/A
Role of ALiskiren, a Direct Renin Inhibitor, in Preventing Atrial Fibrillation in Patients With a Pacemaker; RALF.
- Status
- UNKNOWN
- Phase
- PHASE3
Sleep Apnea and Atrial Fibrillation Recurrence
- Status
- COMPLETED
- Phase
- NA
SDM for Stroke Prevention in Atrial Fibrillation
- Status
- COMPLETED
- Phase
- NA
Use of Public Health Surveillance Models in the French National Health System Database
- Status
- COMPLETED
- Phase
- N/A